PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC9705435::ACT054507

Bradykinin

Evidence text

Paper-level observation

Figure 4b: Bradykinin injection induced a decrease in MAP (~Δ 23 mmHg)
unknownConfidence: medium

Assay observation

Activity
Metabolic/Cardiovascular
Subtype
Other
Measure
other
Comparator
=
Raw observation
~Δ 23 mmHg
Normalized measurement
=23 other
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Rattus norvegicus
Assay method
Not reported by source
Sequence
RPPGFSPFR
Standardization
ready simple
Assay conditions
"original_unit=mmHg"

Source publication

Thiocarbazate building blocks enable the construction of azapeptides for rapid development of therapeutic candidates.

Nature Communications · 2022

DOI 10.1038/s41467-022-34712-9 PMC9705435
Parent mention Integrated peptide

Related peptide identities

PEPDIA-PLP-003998PEPDIA-INT-058212

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.